Atlas Trials

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Clinical trial NCT02049034 · COMPLETED

Trial details

NCT number
NCT02049034
Sponsor
University of Surrey
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2014-01-01
Primary completion
2016-01-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.